LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on the respiratory syncytial virus. The report includes a comprehensive research on the pipeline molecules ...

DUBLIN, April 16, 2020 /PRNewswire/ -- The "US Respiratory Drug Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The US respiratory drug market was around $15 billion in ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Respiratory Drug Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific respiratory drug market was valued at $9.8 ...

COLUMBIA — A Columbia area drug maker is spending $81 million to increase production of generic respiratory medications and other pharmaceuticals. The Ritedose Corporation's production increase comes ...

Opinions expressed by Digital Journal contributors are their own. As healthcare systems worldwide continue to address the effects of the COVID-19 pandemic, pharmaceutical companies like Amneal ...

Hospitals across the U.S. face shortages of the drug albuterol, used to treat respiratory illnesses. Supplies of the drug were reduced over a fall and winter by patients with RSV, influenza and ...

COLUMBIA — Two South Carolina companies that make drugs used to treat respiratory illnesses and symptoms, like those experienced by people infected with the coronavirus, have upped their production ...

Dublin, April 21, 2020 (GLOBE NEWSWIRE) -- The "Asia-Pacific Respiratory Drug Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific respiratory drug market was ...

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.